참고문헌
- Baak JPA. Mitosis counting in tumors. Hum Pathol. 1990. 21: 683-685. https://doi.org/10.1016/0046-8177(90)90026-2
- Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol. 2006. 30: 657-664. https://doi.org/10.1097/01.pas.0000202048.28203.25
- Harpole DH Jr, Feldman JM, Buchanan S, Young WG, Wolfe WG. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg. 1992. 54: 50-54. https://doi.org/10.1016/0003-4975(92)91139-Z
- Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP, Th'ng JP. Chromatin condensation is not associated with apoptosis. J Biol Chem. 1998. 273: 24470-24478. https://doi.org/10.1074/jbc.273.38.24470
- Kapur P, Rakheja D, Balani JP, Roy L, Amirkhan RH, Hoang MP. Phosphorylated histone H3, Ki-67, p21, fatty acid synthase, and cleaved caspase-3 expression in benign and atypical granular cell tumors. Arch Pathol Lab Med. 2007. 131: 57-64.
- Kim YJ, Ketter R, Steudel WI, Feiden W. Prognostic significance of the mitotic index using the mitosis marker antiphosphohistone H3 in meningiomas. Am J Clin Pathol. 2007. 128: 118-125. https://doi.org/10.1309/HXUNAG34B3CEFDU8
- Lee CH, Chang HK, Lee HW, Shin DH, Roh MS. The interobserver variability for diagnosing pulmonary carcinoid tumor. Korean J Pathol. 2010. 44: 267-271. https://doi.org/10.4132/KoreanJPathol.2010.44.3.267
- Lim E, Goldstraw P, Nicholson AG, Travis WD, Jett JR, Ferolla P, Bomanji J, Rusch VW, Asamura H, Skogseid B, Baudin E, Caplin M, Kwekkeboom D, Brambilla E, Crowley J. Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors. 2007. J Thorac Oncol. 2008. 3: 1194-1201. https://doi.org/10.1097/JTO.0b013e3181861d7b
- Marty-Ane CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H. Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg. 1995. 9: 78-83.
- Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004. 28: 1532 -1536. https://doi.org/10.1097/01.pas.0000141389.06925.d5
- Scott IS, Heath TM, Morris LS, Rushbrook SM, Bird K, Vowler SL, Arends MJ, Coleman N. A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens. Br J Cancer. 2004. 90: 1583-1590. https://doi.org/10.1038/sj.bjc.6601660
- Shibata K, Inaaki M, Ajiro K. Mitosis-specific histone H3 phsophorylation in vitro in nucleosome structures. Eur J Biochem. 1990. 192: 87-93. https://doi.org/10.1111/j.1432-1033.1990.tb19199.x
- Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K. Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol. 2006. 30: 83-89. https://doi.org/10.1097/01.pas.0000183572.94140.43
- Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998a. 22: 934-944. https://doi.org/10.1097/00000478-199808000-00003
- Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol. 1998b. 29: 272-279. https://doi.org/10.1016/S0046-8177(98)90047-8
- Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization Classification of Tumour. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. 2004. IARC press. Lyon, France.